256 related articles for article (PubMed ID: 10517668)
1. Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells.
McGowan EM; Clarke CL
Mol Endocrinol; 1999 Oct; 13(10):1657-71. PubMed ID: 10517668
[TBL] [Abstract][Full Text] [Related]
2. Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells.
Graham JD; Yager ML; Hill HD; Byth K; O'Neill GM; Clarke CL
Mol Endocrinol; 2005 Nov; 19(11):2713-35. PubMed ID: 15976005
[TBL] [Abstract][Full Text] [Related]
3. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL
Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737
[TBL] [Abstract][Full Text] [Related]
4. Effect of progesterone receptor a predominance on breast cancer cell migration into bone marrow fibroblasts.
McGowan EM; Saad S; Bendall LJ; Bradstock KF; Clarke CL
Breast Cancer Res Treat; 2004 Feb; 83(3):211-20. PubMed ID: 14758091
[TBL] [Abstract][Full Text] [Related]
5. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
Wu J; Richer J; Horwitz KB; Hyder SM
Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
[TBL] [Abstract][Full Text] [Related]
6. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
Rojas PA; May M; Sequeira GR; Elia A; Alvarez M; MartÃnez P; Gonzalez P; Hewitt S; He X; Perou CM; Molinolo A; Gibbons L; Abba MC; Gass H; Lanari C
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376177
[TBL] [Abstract][Full Text] [Related]
7. Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A.
Pateetin P; Pisitkun T; McGowan E; Boonyaratanakornkit V
J Steroid Biochem Mol Biol; 2020 Apr; 198():105560. PubMed ID: 31809870
[TBL] [Abstract][Full Text] [Related]
8. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
9. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
Arnett-Mansfield RL; deFazio A; Wain GV; Jaworski RC; Byth K; Mote PA; Clarke CL
Cancer Res; 2001 Jun; 61(11):4576-82. PubMed ID: 11389093
[TBL] [Abstract][Full Text] [Related]
10. Cytoskeletal responsiveness to progestins is dependent on progesterone receptor A levels.
McGowan EM; Weinberger RP; Graham JD; Hill HD; Hughes JA; O'Neill GM; Clarke CL
J Mol Endocrinol; 2003 Oct; 31(2):241-53. PubMed ID: 14519093
[TBL] [Abstract][Full Text] [Related]
11. The anti-progestin RU486 stabilizes the progestin-induced fatty acid synthetase mRNA but does not stimulate its transcription.
Chalbos D; Galtier F; Emiliani S; Rochefort H
J Biol Chem; 1991 May; 266(13):8220-4. PubMed ID: 2022639
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the expression and activity by progestins of a member of the SOX gene family of transcriptional modulators.
Graham JD; Hunt SM; Tran N; Clarke CL
J Mol Endocrinol; 1999 Jun; 22(3):295-304. PubMed ID: 10343288
[TBL] [Abstract][Full Text] [Related]
13. An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity.
Wei LL; Hawkins P; Baker C; Norris B; Sheridan PL; Quinn PG
Mol Endocrinol; 1996 Nov; 10(11):1379-87. PubMed ID: 8923464
[TBL] [Abstract][Full Text] [Related]
14. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
Wu J; Brandt S; Hyder SM
Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
[TBL] [Abstract][Full Text] [Related]
15. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.
Mote PA; Bartow S; Tran N; Clarke CL
Breast Cancer Res Treat; 2002 Mar; 72(2):163-72. PubMed ID: 12038707
[TBL] [Abstract][Full Text] [Related]
16. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
Wargon V; Riggio M; Giulianelli S; Sequeira GR; Rojas P; May M; Polo ML; Gorostiaga MA; Jacobsen B; Molinolo A; Novaro V; Lanari C
Int J Cancer; 2015 Jun; 136(11):2680-92. PubMed ID: 25363551
[TBL] [Abstract][Full Text] [Related]
17. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1.
Abascal MF; Elia A; Alvarez M; Pataccini G; Sequeira G; Riggio M; Figueroa V; Lamb CA; Rojas PA; Spengler E; MartÃnez-Vazquez P; Burruchaga J; Liguori M; Sahores A; Wargon V; Molinolo A; Hewitt S; Lombes M; Sartorius C; Vanzulli SI; Giulianelli S; Lanari C
Int J Cancer; 2022 May; 150(9):1481-1496. PubMed ID: 34935137
[TBL] [Abstract][Full Text] [Related]
19. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
[TBL] [Abstract][Full Text] [Related]
20. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.
Arnett-Mansfield RL; DeFazio A; Mote PA; Clarke CL
J Clin Endocrinol Metab; 2004 Mar; 89(3):1429-42. PubMed ID: 15001645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
